Based on 11 Wall Street analysts offering 12 month price targets for AbbVie in the last 3 months. The average price target is $164.44 with a high forecast of $195.00 and a low forecast of $141.00. The average price target represents a 11.75% change from the last price of $147.15.
What are Abbvie's 12 month price targets?
13 equities research analysts have issued 12 month price objectives for AbbVie's stock. Their ABBV share price targets range from $150.00 to $196.00. On average, they anticipate the company's stock price to reach $174.31 in the next year. This suggests a possible upside of 7.9% from the stock's current price.
What is the sales forecast for abbv?
Next quarter’s sales forecast for ABBV is $13.48B with a range of $12.95B to $13.67B. The previous quarter’s sales results were $12.22B. ABBV beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 42.78% of the time in the same period.
